capital markets

The preliminary decision to block Cosette's acquisition of Mayne Pharma sets a bad precedent and would weaken Australia's capital markets.

The major developments at Macquarie, plus broker views, consensus ratings, and price targets, as well as the technical analysis outlook.

If investors haven't entirely turned off the tap, it has certainly been turned down to a trickle. The $US146 billion of equity capital raised globally in the March...

The pace of US IPO activity has shattered previous records.It is a clear sign of excess and market froth.The stampede into IPOs reflects (past) performance.Increasing...

The past few weeks have been quiet in capital markets. Deals are still being done but the sentiment certainly feels more subdued than the 20-raise-a-week days of...

We're covering two week's worth of raises in this edition. The week of the 7th September saw $477m of fresh equity issued across 21 transactions. Nearmap, PointsBet...

Just under $698m was raised this week across 23 placements. The largest among them were for IOOF ($452m) and Orocobre ($126m). There hasn't been as many rescue raises...

As the world grapples with COVID-19 and the worst economic downtown since the Great Depression, global stock markets surpass all-time highs. These conflicting...

Just over $280m of funding was raised this week for listed Aussie companies. Of the 24 raises that were completed, more than 70% of the capital went to Splitit (SPT) ,...

The week before last was one of the slowest of the year in capital markets, barely $100m was raised and the majority of volume was concentrated at the smaller end of...